The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study

被引：0
|
作者：
Corren, J. [1 ]
Menzies-Gow, A. [2 ]
Ambrose, C. S. [3 ]
Cook, B. [3 ]
Kmita, K. [4 ]
Colice, G. [5 ]
Llanos-Ackert, J. [6 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Royal Brompton Hosp, London, England
[3] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[4] AstraZeneca, BioPharmaceut R&D, Biometr Late Stage Dev Resp & Immunol, Warsaw, Poland
[5] Astrazeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gaithersburg, MD USA
[6] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
679
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
    Corren, Jonathan
    Ambrose, Christopher S. S.
    Griffiths, Janet M. M.
    Hellqvist, Asa
    Lindsley, Andrew W. W.
    Llanos, Jean-Pierre
    Colice, Gene
    Menzies-Gow, Andrew
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 417 - 428
  • [2] The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
    Corren, J.
    Colice, G.
    Salapa, K.
    Bowen, K.
    Llanos-Ackert, J.
    [J]. ALLERGY, 2020, 75 : 19 - 19
  • [3] Tezepelumab Efficacy in Patients with Allergic and Non-Allergic Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
    Corren, Jonathan
    Colice, Gene
    Salapa, Kinga
    Bowen, Karin
    Llanos-Ackert, Jean-Pierre
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB157 - AB157
  • [4] Efficacy of tezepelumab in patients with severe, uncontrolled asthma, according to baseline blood eosinophil count and allergic status: results from the phase 3 NAVIGATOR study
    Menzies-Gow, A.
    Corren, J.
    Cook, B.
    Kmita, K.
    Llanos-Ackert, J.
    Colice, G.
    Ambrose, C. S.
    [J]. ALLERGY, 2021, 76 : 21 - 22
  • [5] Omalizumab in allergic and non-allergic patients: results of FENOMA study
    Mardones Charroalde, Aizea
    Campo Mozo, Paloma
    Soto Campos, Jose Gregorio
    Moreira Jorge, Ana
    Davila Gonzalez, Ignacio Jesus
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma
    Shahana, S
    Björnsson, E
    Lúvíksdóttir, D
    Janson, C
    Nettelbladt, O
    Venge, P
    Roomans, GM
    [J]. RESPIRATORY MEDICINE, 2005, 99 (04) : 429 - 443
  • [7] Prognosis of allergic and non-allergic asthma
    Rask-Andersen, Anna
    Uddenfeldt, Monica
    Lampa, Erik
    Janson, Christer
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [8] Burden of illness of patients with allergic asthma versus non-allergic asthma
    Lafeuille, Marie-Helene
    Gravel, Jonathan
    Figliomeni, Maria
    Zhang, Jie
    Lefebvre, Patrick
    [J]. JOURNAL OF ASTHMA, 2013, 50 (08) : 900 - 907
  • [9] Influence of non-allergic factors total immunoglobulin E in patients with non-allergic asthma
    Dubuske, L.
    Novikova, T.
    Dotsenko, E.
    Sholkova, M.
    [J]. ALLERGY, 2021, 76 : 124 - 124
  • [10] Effect of Tezepelumab in Oral Corticosteroid-Dependent Patients with Severe Asthma: Results From the Phase 3 NAVIGATOR Study
    Menzies-Gow, A.
    Brightling, C. E.
    Ambrose, C. S.
    Cook, B.
    Hellgvist, A.
    Ackert, J. Llanos
    Colice, G.
    Wechsler, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345